Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOFLOXACIN vs LEVOLEUCOVORIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOFLOXACIN vs LEVOLEUCOVORIN: Safety Overview

Metric LEVOFLOXACIN LEVOLEUCOVORIN
Total FAERS Reports 40,403 3,168
Deaths Reported 2,747 421
Death Rate 6.8% 13.3%
Hospitalizations 13,832 1,413
Average Patient Age 59.4 yrs 64.9 yrs
% Female Patients 54.7% 36.1%
FDA Approval Date Apr 22, 2020 Apr 29, 2011
Manufacturer BPI LABS LLC Hikma Pharmaceuticals USA Inc.
Route OPHTHALMIC INTRAVENOUS
Marketing Status Discontinued Discontinued